Vascular endothelial growth factor (VEGF)-A165b is a COOH-terminal splice variant of VEGF-
A that has been implicated in negative regulation of angiogenesis. We compared the …

Vascular endothelial growth factor-A (VEGF-A) has long been recognized as the key
regulator of vascular development and function in health and disease. VEGF is a secreted …

Angiogenesis, the formation of new blood vessels from pre–-existing ones, is central for both
normal development and homeostasis as well as in certain pathological conditions. The …

Vascular endothelial growth factor (VEGF) is a key mediator of angiogenesis, whose effect
on cancer growth and development is well characterized. Alternative splicing of VEGF leads …

Neuroplin-1 (NRP1), a receptor for vascular endothelial growth factor (VEGF) family
members, has three distinct extracellular domains, a1a2, b1b2, and c. To determine the …

The regulation of vascular endothelial growth factor A (VEGF) is critical to
neovascularization in numerous tissues under physiological and pathological conditions …

VEGFs (vascular endothelial growth factors) are master regulators of vascular development
and of blood and lymphatic vessel function during health and disease in adults. This family …

Receptor-type tyrosine kinases are known to be involved in a wide variety of biological
processes, such as cell growth, differentiation, morphogenesis and malignant …

Neuropilin (NRP) expression is highly correlated with poor outcome in multiple cancer
subtypes. As known coreceptors for VEGFRs, core drivers of angiogenesis, past …

Vascular endothelial growth factors (VEGFs) interact with the receptor tyrosine kinases
(RTKs) VEGFR‐1,‐2, and‐3; neuropilins (NRPs); and heparan sulfate (HS) proteoglycans …